Cronos Group Inc.

Equities

CRON

CA22717L1013

Pharmaceuticals

Market Closed - Toronto S.E. 04:00:00 2024-03-01 pm EST 5-day change 1st Jan Change
2.75 CAD -3.17% Intraday chart for Cronos Group Inc. -9.24% -0.72%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cronos Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Toronto Stocks Advance; Canadian Imperial Bank of Commerce Up on 1Q Profit, Revenue Rise DJ
Cronos Group Reports Consolidated Net Revenue Rose 9% in Q4 2023 MT
Transcript : Cronos Group Inc., Q4 2023 Earnings Call, Feb 29, 2024
Cronos Group Brief: Says Ended 2023 with approximately US$862 million in cash and short-term investments MT
Cronos Group Brief: Net revenue in Canada increased 20% in Q4 2023 Vs Q4 2022; On a constant currency basis net revenue in Canada increased 21% in Q4 2023 Vs Q4 2022 MT
Cronos Group Brief: On a constant currency basis consolidated net revenue increased 11% in Q4 2023 compared to Q4 2022 MT
Cronos Group Brief: Consolidated net revenue increased 9% in Q4 2023 compared to Q4 2022 MT
Cronos Group Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
North American Morning Briefing : Fed's Preferred -2- DJ
Cronos Group Entering Australian Cannabis Market MT
Cronos Group Brief: Entering Australian Cannabis Market MT
Cronos Group Inc. Announces Launch of Its Highly Anticipated Lord Jones Live Resin Vapes in Two Different Hardware Options CI
Cronos Group Edges Down Premarket as it Raises C$23 Million in a Sale and Leaseback of an Ontario Property MT
Cronos Group Brief: Entering into agreement for the sale-leaseback of its Stayner, Ontario facility MT
Future Farmco Canada Inc. entered into an agreement to acquire Peace Naturals Project Inc. from Cronos Group Inc. for CAD 23 million. CI
Transcript : Cronos Group Inc., Q3 2023 Earnings Call, Nov 08, 2023
Cronos Group Up 3.7% Premarket as its Q3 Loss Narrows on Sales Gain MT
Cronos Group Brief: Company maintains its expectation that the net change in cash will be positive in 2024 MT
Cronos Group Brief: Anticipates that net change in cash, defined as sum of cash and cash equivalents and short-term investments, will decline by less than US$5-$10 million in the last three months of fiscal year 2023 MT
Cronos Group Brief: Reiterates its previously announced operating expense savings target of US$20-$25 million in 2023, and planned incremental operating expense savings of $10-$15 million in 2024 MT
Cronos Group Brief: Citing "Industry-leading" balance sheet with US$840 million in cash and short-term investment MT
Cronos Group Brief: On a constant currency basis, net revenue in Q3 2023 increased by 27% year-over-year to US$26.0 million MT
Cronos Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Cronos Group Brief: Net revenue in Q3 2023 increased by 22% year-over-year to US$24.8 million MT
Chart Cronos Group Inc.
More charts
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, Lord Jones, Happy Dance and PEACE+. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd., Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd., and Cronos Israel G.S. Pharmacy Ltd.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
2.75 CAD
Average target price
3.39 CAD
Spread / Average Target
+23.27%
Consensus
  1. Stock
  2. Equities
  3. Stock Cronos Group Inc. - Toronto S.E.
  4. News Cronos Group Inc.
  5. Cronos Group Edges Down Premarket as it Raises C$23 Million in a Sale and Leaseback of an Ontario Property
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW